Clinical trial
Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head…
NCT00017277 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Terminated
Key facts
| NCT number | NCT00017277 |
|---|---|
| Title | Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer |
| Official title | A Phase III Double-Blind, Randomized, Placebo-Controlled Study of Erythropoietin When Used as an Adjuvant to Radiation Therapy in Patients With Head and Neck Squamous Cell Carcinoma |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Collaborators | Trans Tasman Radiation Oncology Group Charite University, Berlin, Germany Groupe Oncologie Radiotherapie Tete et Cou Radius Hungaricus Oncology Group Grup per l'Estudi dels Limfomes de Catalunya i… |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Biological, Radiation |
| Interventions | epoetin alfa, radiation therapy |
| Enrollment | 47 |
| Start date | Mar 1, 2001 |
| Primary completion | Apr 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 24, 2012 |
| Countries | Australia, Belgium, France, Germany, Hungary, Israel, Netherlands, Spain, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: